| Literature DB >> 26274378 |
Keiji Itaka1, Satoshi Uchida2, Akitsugu Matsui2, Kayoko Yanagihara2, Masaru Ikegami2, Taisuke Endo3, Takehiko Ishii4, Kazunori Kataoka3.
Abstract
To improve the therapeutic effectiveness of cell transplantation, a transplantation system of genetically modified, injectable spheroids was developed. The cell spheroids are prepared in a culture system on micropatterned plates coated with a thermosensitive polymer. A number of spheroids are formed on the plates, corresponding to the cell adhesion areas of 100 µm diameter that are regularly arrayed in a two-dimensional manner, surrounded by non-adhesive areas that are coated by a polyethylene glycol (PEG) matrix. The spheroids can be easily recovered as a liquid suspension by lowering the temperature of the plates, and their structure is well maintained by passing them through injection needles with a sufficiently large caliber (over 27 G). Genetic modification is achieved by gene transfection using the original non-viral gene carrier, polyplex nanomicelle, which is capable of introducing genes into cells without disrupting the spheroid structure. For primary hepatocyte spheroids transfected with a luciferase-expressing gene, the luciferase is sustainably obtained in transplanted animals, along with preserved hepatocyte function, as indicated by albumin expression. This system can be applied to a variety of cell types including mesenchymal stem cells.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26274378 PMCID: PMC4545087 DOI: 10.3791/52384
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355